УДК 616-006.66:618.11-006.6:575.113:575.224.2

A.I. Khasanova1,2, M.G. Gordiev1,2, E.Yu. Ratner¹, V.V. Zhavoronkov1,2, R.Sh. Khasanov1,2, A.G. Nikitin4  
1Tatarstan Cancer Center, Kazan
2Volga Region branch of N.N. Blokhin Russian Cancer Research Center, Kazan
3Kazan State Medical Academy, Kazan
4Federal Scientific Clinical Center of Specialized Types of Medical Care and Medical Technologies FMBA of Russia, Moscow

Khasanova A.I. ― Cand. Med. Sc., oncologist of the Tatarstan Cancer Center
29 Sibirskiy Trakt, Kazan, Russian Federation, 420029, tel. (843) 525-73-97, e-mail:

Abstract. During medical and genetic counseling of representative of the tatar nationality group with anamnesis of breast cancer and ovarian cancer, as well as a family history of cancer in exon 10 of BRCA1 gene was detected nucleotide substitution s.915T>A in heterozygous state. With direct sequencing method were automatically analyzed exons 2, 4, 5, 10, 12-17 and adjacent intronic regions of BRCA1 gene. This replacement is not described in the databases BRCA Share, Breast Cancer Information Core database, LOVD, HGMD Professional and can be classified as previously not published disease-causing mutation leading to premature termination of translation.

Key words: breast cancer, ovarian cancer, mutations and polymorphisms of BRCA1/2 gene, ethnogeographical features of distribution, tatar population.

1.    Minimal'nye klinicheskie rekomendatsii ECMO [Minimum Clinical Recommendations ECMO], 2010.
2.    Zlokachestvennye zabolevaniya v Rossii v 2013 g. (zabolevaemost' i smertnost'), pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoy [Malignant disease in Russia in 2013 (morbidity and mortality). Ed. by A.D. Caprin, V.V. Starinskiy, G.V. Petrova]. Moscow, 2015.  
3.    Imyanitov E.N. Prakticheskaya onkologiya [Practical Oncology]. Vol. 11, no. 4, 2010.
4.    Lyubchenko L.N., Bateneva E.I. Mediko-geneticheskoe konsul'tirovanie i DNK-diagnostika pri nasledstvennoy predraspolozhennosti k raku molochnoy zhelezy i raku yaichnikov [Medical and genetic counseling and DNA diagnostics in hereditary predisposition to breast cancer and ovarian cancer]. Moscow, 2014. 76 p.
5.    Lyubchenko L.N. Nasledstvennyy rak molochnoy zhelezy i/ili yaichnikov: DNK-diagnostika, individual'nyy prognoz, lechenie i profilaktika: dis. … d-ra med. nauk [Hereditary breast cancer and/or ovarian cancer: DNA diagnostics, individual prognosis, treatment and prevention. Synopsis of dis. Dr med. sciences]. Moscow, 2009. 281 p.
6.    Anisimenko M.S., Afanas'eva N.A., Chasovnikova O.B., Krasil'nikov S.E. Analysis 5382insC mutation incidence in BRCA1 gene in ovarian cancer patients in the Siberian region. Sibirskiy onkologicheskiy zhurnal, 2012, no. 4 (52), pp. 39-42 (in Russ.).
7.    Foulkes W.D., Wong N., Brunet J.S. et al. Germline BRCAl mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin. Cancer Res, 1997, vol. 3, pp. 2465-9. 
8.    Farakhtdinova A.R., Fedorova S.A., Nikolaeva T.I. et al.  Analysis of mutations in the BRCA1 gene, CHEK 2, NBS1 in breast cancer patients from the Republic of Sakha (Yakutia). Yakutskiy Meditsinskiy zhurnal, 2009, 2 (26), pp. 91-93 (in Russ.).
9.    Bermisheva M.A., Zinnatullina G.F., Khusnutdinova E.K. The frequency of mutations 5382insC gene BRCA1. Voprosy onkologii, 2008, vol. 54, no.1, pp. 31-34 (in Russ.).
10.    Fedorova S.A. Etnogenomika korennykh narodov respubliki Sakha (Yakutiya): avtoref. dis. … d-ra biol. nauk [Ethnogenomics indigenous peoples of the Republic of Sakha (Yakutia). Synopsis of dis. Dr biol. sciences]. Moscow, 2008.
11.    Seynaeve C. et al. Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur. J. Cancer, 2004, 40 (8), pp. 1150-8. doi: 10.1016/j.ejca.2004.01.017. [PubMed] [Cross Ref].
12.    Coppa A., Buffone A., Capalbo C. et al. Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14. Breast Cancer Res. Treat, 2014, Dec, 148 (3), pp. 629-35.
13.    Ferla R., Carlo’V., Casio S. et al. Founder mutations in BRCA1 and BRCA2 genes. Ann. Oncol, 2007, vol. 18 (suppl.6), pp. 93-98.
14.    Breast Cancer Information Core (BIC), available at: